261 related articles for article (PubMed ID: 26236031)
1. Abnormalities in brain structure and biochemistry associated with mdx mice measured by in vivo MRI and high resolution localized (1)H MRS.
Xu S; Shi D; Pratt SJP; Zhu W; Marshall A; Lovering RM
Neuromuscul Disord; 2015 Oct; 25(10):764-72. PubMed ID: 26236031
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
3. Electrical impedance myography detects dystrophin-related muscle changes in mdx mice.
Hiyoshi T; Zhao F; Baba R; Hirakawa T; Kuboki R; Suzuki K; Tomimatsu Y; O'Donnell P; Han S; Zach N; Nakashima M
Skelet Muscle; 2023 Nov; 13(1):19. PubMed ID: 37980539
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities in Brain and Muscle Microstructure and Neurochemistry of the DMD Rat Measured by
Xu S; Tang S; Li X; Iyer SR; Lovering RM
Front Neurosci; 2020; 14():739. PubMed ID: 32760246
[TBL] [Abstract][Full Text] [Related]
5. Brain and heart magnetic resonance imaging/spectroscopy in duchenne muscular dystrophy.
Mavrogeni S; Pons R; Nikas I; Papadopoulos G; Verganelakis DA; Kolovou G; Chrousos GP
Eur J Clin Invest; 2017 Dec; 47(12):. PubMed ID: 28981141
[TBL] [Abstract][Full Text] [Related]
6. Brain function in Duchenne muscular dystrophy.
Anderson JL; Head SI; Rae C; Morley JW
Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment appears progressive in the mdx mouse.
Bagdatlioglu E; Porcari P; Greally E; Blamire AM; Straub VW
Neuromuscul Disord; 2020 May; 30(5):368-388. PubMed ID: 32360405
[TBL] [Abstract][Full Text] [Related]
8. Altered release and uptake of gamma-aminobutyric acid in the cerebellum of dystrophin-deficient mice.
Pereira da Silva JD; Campos DV; Nogueira-Bechara FM; Stilhano RS; Han SW; Sinigaglia-Coimbra R; Lima-Landman MTR; Lapa AJ; Souccar C
Neurochem Int; 2018 Sep; 118():105-114. PubMed ID: 29864448
[TBL] [Abstract][Full Text] [Related]
9. Brain metabolism is abnormal in the mdx model of Duchenne muscular dystrophy.
Tracey I; Dunn JF; Radda GK
Brain; 1996 Jun; 119 ( Pt 3)():1039-44. PubMed ID: 8673481
[TBL] [Abstract][Full Text] [Related]
10. Dystrophic Dmd
Krishnan VS; Thanigaiarasu LP; White R; Crew R; Larcher T; Le Guiner C; Grounds MD
Mol Cell Neurosci; 2020 Oct; 108():103549. PubMed ID: 32890728
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
Wu WC; Bradley SP; Christie JM; Pugh JR
J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
[TBL] [Abstract][Full Text] [Related]
12. Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy.
Aranmolate A; Tse N; Colognato H
BMC Neurosci; 2017 Aug; 18(1):63. PubMed ID: 28806929
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits.
Heier CR; Guerron AD; Korotcov A; Lin S; Gordish-Dressman H; Fricke S; Sze RW; Hoffman EP; Wang P; Nagaraju K
PLoS One; 2014; 9(11):e112477. PubMed ID: 25390038
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile of dystrophic mdx mouse muscles analyzed with in vitro magnetic resonance spectroscopy (MRS).
Martins-Bach AB; Bloise AC; Vainzof M; Rahnamaye Rabbani S
Magn Reson Imaging; 2012 Oct; 30(8):1167-76. PubMed ID: 22673895
[TBL] [Abstract][Full Text] [Related]
15. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
[TBL] [Abstract][Full Text] [Related]
16. Structural and Functional Alterations of Skeletal Muscle Microvasculature in Dystrophin-Deficient mdx Mice.
Latroche C; Matot B; Martins-Bach A; Briand D; Chazaud B; Wary C; Carlier PG; Chrétien F; Jouvion G
Am J Pathol; 2015 Sep; 185(9):2482-94. PubMed ID: 26193666
[TBL] [Abstract][Full Text] [Related]
17. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse.
Kueh SL; Dempster J; Head SI; Morley JW
Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance quantification of skeletal muscle lipid infiltration in a humanized mouse model of Duchenne muscular dystrophy.
Khattri RB; Batra A; Matheny M; Hart C; Henley-Beasley SC; Hammers D; Zeng H; White Z; Ryan TE; Barton E; Bernatchez P; Walter GA
NMR Biomed; 2023 Mar; 36(3):e4869. PubMed ID: 36331178
[TBL] [Abstract][Full Text] [Related]
19. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation.
Barker RG; Wyckelsma VL; Xu H; Murphy RM
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C483-C491. PubMed ID: 29351413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
